2cureX AB (publ) (STO:2CUREX)
Sweden · Delayed Price · Currency is SEK 2.290
+0.040 (1.78%)
Apr 24, 2026, 5:29 PM CET
2cureX AB Earnings Call Transcripts
Fiscal Year 2024
-
Two new board members were elected to drive a transformation, including a shift to a direct-to-patient commercial model and the sale of the Danish-German subsidiary. The company is preparing for IVD-R certification and plans to scale operations, with proceeds from the asset sale to be distributed to shareholders.